91 results
8-K
EX-1.1
ABBV
Abbvie Inc
26 Feb 24
Other Events
5:08pm
, in connection with the defense thereof other than reasonable costs of investigation.
(d) To the extent the indemnification provided for in Sections 8 … in this Agreement shall remain operative and in full force and effect regardless of (i) any termination of this Agreement, (ii) any investigation made
PX14A6G
Friends Fiduciary Corp
11 Apr 22
Letter to shareholders
4:35pm
should shareholders be concerned with anticompetitive practices at AbbVie?
A three-year investigation on drug pricing by the U.S. House Committee … increased 25 times resulting in a 471% price increase since its launch, with Imbruvica’s price also increasing 82%.11
The Committee’s investigation also
8-K
EX-99.1
wj674gtl
30 Jul 21
AbbVie Reports Second-Quarter 2021 Financial Results
7:52am
PX14A6G
yph05mj5opnxh3fb17oz
15 Apr 21
Letter to shareholders
1:10pm
S-8
EX-4.3
pjecl9 x0
19 Jun 20
Registration of securities for employees
5:01pm
S-3ASR
EX-5.1
ezl9l bovowwy
15 May 20
Automatic shelf registration
12:00am
8-K
EX-4.23
6378738
14 May 20
AbbVie Announces Final Results of Exchange Offers for Allergan Notes
4:16pm
8-K
EX-4.13
6wuz6afn 26
26 Nov 19
Entry into a Material Definitive Agreement
8:45am